EXEO Capital acquires stake in SA’s only manufacturer of animal active pharmaceutical ingredients
The local pharmaceutical industry has the ability to make a significant contribution to South Africa’s gross domestic product as well as Africa’s broader socioeconomic landscape. There are, however, very few examples of successful homegrown pharmaceutical companies that address this opportunity and the national and pan-African imperative to establish an African-based pharmaceutical synthesis sector. This deep-seated conviction has underpinned the decision by pan-African alternative investment firm EXEO Capital to acquire a majority stake in cutting edge, chemical synthesis company, Chemical Process Technologies (CPT).
